Skip to content
Gymnema (Gymnema sylvestre)

Apocynaceae · leaf

Gymnema

Gymnema sylvestre

Human clinical trialsUse with caution

Ayurvedic leaf (gurmar, 'sugar destroyer') mapped to modest human glycemic trials. Evidence is human-level but not definitive disease modification.

Safety first

Leaf can blunt sweet taste and has human glucose-parameter trials. It can add to hypoglycemia with diabetes drugs and is not a substitute for diabetes care.

Tradition vs trials

Traditional record. API and Ayurvedic practice use the leaf in kapha/madhumeha-type metabolic patterns. That mapping is traditional.

Trial literature. Small to moderate human trials report changes in fasting glucose or sweet-taste perception. Products and gymnemic-acid assays vary.

Practical ranges

Educational ranges — not a prescription. Culinary use is not an extract.

  • leaf extract

    Human glycemic trials often use a few hundred milligrams of extract (standardized to gymnemic acids) daily; crude-leaf traditional amounts differ — not a prescription

    Ayurvedic Pharmacopoeia of India (API)Educational range only — not a prescription. A licensed clinician individualizes product, dose, and duration.

Pregnancy, nursing, children

  • Pregnancy. Insufficient reliable data; avoid unless a clinician directs otherwise.
  • Nursing. Insufficient reliable data; avoid unless a clinician directs otherwise.
  • Children. Insufficient reliable data; avoid unless a clinician directs otherwise.

Contraindications

  • do not replace prescribed diabetes therapy
  • known Apocynaceae allergy

Key interactions

  • insulin and oral antidiabetes drugs · caution

    Additive hypoglycemia is the main practical risk.

Open drug–herb checker

Used in these diagnoses